Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ZEPP Stock Forecast 2026-2027
$4.69
Current Price
$68.78M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ZEPP Price Targets
+1,100.0%
To High Target of $56.28
+1,100.0%
To Median Target of $56.28
+1,100.0%
To Low Target of $56.28
ZEPP Price Momentum
-24.2%
1 Week Change
-54.6%
1 Month Change
+103.0%
1 Year Change
-82.6%
Year-to-Date Change
-92.4%
From 52W High of $61.85
+108.4%
From 52W Low of $2.25
📊 TOP ANALYST CALLS
Did ZEPP Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Zepp Health is one of their latest high-conviction picks.
Latest ZEPP Stock Price Targets & Analyst Predictions
Wall Street analysts covering ZEPP have a bullish consensus with a median price target of $56.28 (ranging from $56.28 to $56.28). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $4.69, the median forecast implies a 1,100.0% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ZEPP Analyst Ratings
1
Buy
0
Hold
0
Sell
ZEPP Price Target Range
Low
$56.28
Average
$56.28
High
$56.28
Current: $4.69
Latest ZEPP Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ZEPP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Zepp Health Corp. Depositary Receipt (ZEPP) Competitors
The following stocks are similar to Zepp Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zepp Health Corp. Depositary Receipt (ZEPP) Financial Data
Zepp Health Corp. Depositary Receipt has a market capitalization of $68.78M with a P/E ratio of -1.8x. The company generates $271.91M in trailing twelve-month revenue with a -14.7% profit margin.
Revenue growth is +33.8% quarter-over-quarter, while maintaining an operating margin of -33.9% and return on equity of -18.8%.
Valuation Metrics
Market Cap
$68.78M
Enterprise Value
$152.90M
P/E Ratio
-1.8x
PEG Ratio
69.3x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+33.8%
Gross Margin
+37.7%
Operating Margin
-33.9%
Net Margin
-14.7%
EPS Growth
+33.8%
Financial Health
Cash/Price Ratio
+70.4%
Current Ratio
0.9x
Debt/Equity
66.1x
ROE
-18.8%
ROA
-3.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Zepp Health Corp. Depositary Receipt (ZEPP) Business Model
About Zepp Health Corp. Depositary Receipt
What They Do
Global leader in smart wearable and health technology.
Business Model
Zepp Health generates revenue by developing, manufacturing, and selling a diverse range of smart health devices, including smartwatches and biometric sensors, under recognized brands. The depositary receipt structure allows international investors to indirectly own shares and benefit from the company's market performance.
Additional Information
Founded in 2013 and rebranded in 2021, Zepp Health has shipped over 200 million devices and operates in more than 90 countries, highlighting its significant market presence and commitment to innovation in the consumer electronics and healthcare sectors.
Company Information
Sector
Technology
Industry
Consumer Electronics
Employees
765
CEO
Mr. Wang Huang
Country
Netherlands
IPO Year
2018
Website
www.huami.comZepp Health Corp. Depositary Receipt (ZEPP) Latest News & Analysis
Latest News
Quick Summary
Shares of Here Group, Zepp Health, Burning Rock Biotech, and So-Young International saw significant gains last year but have since lost most of those gains in 2026.
Why It Matters
The significant pullback in shares of Here Group, Zepp Health, Burning Rock Biotech, and So-Young International signals potential volatility and risks in their investment outlook for 2026.
Source: Benzinga
Market Sentiment:
Negative
Zepp Health Q1 Earnings Call Highlights
4 days ago
Quick Summary
Zepp Health (NYSE: ZEPP) reported strong Q1 2026 growth, driven by new Amazfit product launches, a higher-end product mix, and expanded positioning in hybrid training.
Why It Matters
Zepp Health's strong Q1 growth, driven by new product launches and an upscale product mix, signals potential revenue growth and market expansion, positively influencing investor sentiment.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Zepp Health Corporation (ZEPP) held its Q1 2026 earnings call, providing updates on financial performance and strategic initiatives. Further details can be found in the full transcript.
Why It Matters
The Q1 2026 earnings call for Zepp Health Corporation provides insights into the company's financial performance and future outlook, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Zepp Health Corporation (NYSE: ZEPP) reported its unaudited financial results for Q1 2026 on June 8, 2026. Further details on performance were not provided in the excerpt.
Why It Matters
Zepp's Q1 2026 financial results will impact its stock performance, providing insights into its growth, profitability, and market position, influencing investor sentiment and decisions.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Amazfit launched the Balance 3 and Balance Ultra smartwatches, enhancing performance tracking with a new Hybrid Training System via the Zepp App, at an event in New York.
Why It Matters
The launch of Amazfit's new smartwatches enhances its competitive edge in the wearable market, potentially driving sales and market share, which can positively influence Zepp Health's stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
An earnings call is scheduled for June 8, 2026, at 9:30 p.m. ET, based in Milpitas, California.
Why It Matters
The scheduled earnings call may reveal financial performance insights, guidance, and strategic direction, impacting stock valuation and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ZEPP Stock
What is Zepp Health Corp. Depositary Receipt's (ZEPP) stock forecast for 2026?
Based on our analysis of 0 Wall Street analysts, Zepp Health Corp. Depositary Receipt (ZEPP) has a median price target of $56.28. The highest price target is $56.28 and the lowest is $56.28.
Is ZEPP stock a good investment in 2026?
According to current analyst ratings, ZEPP has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.69. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ZEPP stock?
Wall Street analysts predict ZEPP stock could reach $56.28 in the next 12 months. This represents a 1,100.0% increase from the current price of $4.69. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Zepp Health Corp. Depositary Receipt's business model?
Zepp Health generates revenue by developing, manufacturing, and selling a diverse range of smart health devices, including smartwatches and biometric sensors, under recognized brands. The depositary receipt structure allows international investors to indirectly own shares and benefit from the company's market performance.
What is the highest forecasted price for ZEPP Zepp Health Corp. Depositary Receipt?
The highest price target for ZEPP is $56.28 from at , which represents a 1,100.0% increase from the current price of $4.69.
What is the lowest forecasted price for ZEPP Zepp Health Corp. Depositary Receipt?
The lowest price target for ZEPP is $56.28 from at , which represents a 1,100.0% increase from the current price of $4.69.
What is the overall ZEPP consensus from analysts for Zepp Health Corp. Depositary Receipt?
The overall analyst consensus for ZEPP is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $56.28.
How accurate are ZEPP stock price projections?
Stock price projections, including those for Zepp Health Corp. Depositary Receipt, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 6:08 PM UTC